Community Medical Center Installation

If you are interested in a MedClean System or MedClean's Waste Hauling brokerage services please click here to request additional information.

MedClean Technologies Signs Contract for Installation of MedClean System at Community Medical Center in Scranton, PA.

Signing is in conjunction with ARAMARK implementing hospital management and expense reduction programs.

BETHLEHEM, PA, November 17, 2011, /PRNewswire-FirstCall/ — MedClean Technologies (OTC Bulletin Board: MCLN), the leading provider of onsite technology for the treatment and disposal of medical waste and the destruction of confidential documents and related media, today announced it has signed an agreement with ARAMARK for the purchase of a MedClean 4300 fixed-based sterilization system.

The agreement includes the purchase and installation of the equipment at Community Medical Center in Scranton, PA, plus additional recurring consumable orders for the life of the equipment, estimated for a period of approximately 10 years.  ARAMARK will provide comprehensive hospital management services that include implementing expense reduction programs that incorporate the use of MedClean’s sterilization technology.  The installation of the equipment is expected to commence and be completed in the fourth quarter of 2011.

“This agreement represents a case study in cooperation amongst ARAMARK, Community Medical Center, and MedClean to achieve beneficial results in the form of expense reductions utilizing MedClean’s fixed-base technology, ARAMARK’s industry leading hospital service capabilities, and Community Medical Center’s own personnel,” commented David Laky, President and CEO of MedClean Technologies, Inc. “We appreciate the fact the we were able to work in partnership with ARAMARK on this project and we will strive to continue to offer beneficial programs to ARAMARK and their valued customers.”

“The deployment of the MedClean 4300 system will enable ARAMARK to reduce its operating costs while continuing to serve the Community Medical Center,” continued Mr. Laky. “Cost effective services and solutions are critical to all organizations in the current economy.”

About ARAMARK

ARAMARK is a leader in professional services, providing award-winning food services, facilities management, and uniform and career apparel to health care institutions, universities and school districts, stadiums and arenas, and businesses around the world. The company is recognized as one of the "World's Most Ethical Companies" by the Ethisphere Institute, as the industry leader in FORTUNE magazine's "World's Most Admired Companies," and as one of America's Largest Private Companies by both FORTUNE and Forbes magazines. ARAMARK seeks to responsibly address issues that matter to its clients, customers, employees and communities by focusing on employee advocacy, environmental stewardship, health and wellness, and community involvement. Headquartered in Philadelphia, ARAMARK has approximately 255,000 employees serving clients in 22 countries. Learn more at www.twitter.com/aramarknews.

About MedClean Technologies, Inc.

MedClean Technologies, Inc. is a provider of innovative technology and services for the onsite treatment and disposal of regulated medical waste. MedClean's flagship MedClean® Series systems are fully integrated, turnkey technology solutions that enable hospitals and other healthcare providers to safely, efficiently, and cost-effectively convert bio-hazardous regulated medical waste into sterile, unrecognizable material suitable for disposal as municipal solid waste. MedClean was founded in 1997 with corporate headquarters, research and development and distribution facilities located in Bethel, Connecticut. Further, information on MedClean can be found at www.medcleantechnologies.com and in filings with the Securities and Exchange Commission found at www.sec.gov.

Statements about our future expectations are "forward-looking statements" within the meaning of applicable Federal Securities Laws, and are not guarantees of future performance. When used herein, the words "may," "will," "should," "anticipate," "believe," "appear," "intend," "plan," "expect," "estimate," "approximate," "potential" and similar expressions are intended to identify such forward-looking statements. These statements involve risks and uncertainties inherent in our business, including those set forth in our most recent Annual Report on Form 10-K for the year ended December 31, 2009, filed with the SEC on March 3, 2010, and other filings with the SEC, and are subject to change at any time. Our actual results could differ materially from these forward-looking statements. We undertake no obligation to update publicly any forward-looking statement.

Company Increases Revenue 96.5% versus 3^rd Quarter 2010.  Revenue Year-to-Date exceeds total revenue for all of 2010.

BETHLEHEM, PA., November 14, 2011 /PRNewswire-FirstCall/ — MedClean Technologies, Inc. (OTC Bulletin Board: MCLN) today announced financial results for the 2011 third quarter for the period ended September 30, 2011.

Some recent highlights include:

The company has dramatically improved its operating structure over the last two years, with improvements to the following key metrics, representing tangible progress:

·         Focus on recurring revenue opportunities will start to add to consistent minimum revenue reported on a quarterly basis:

o   MedClean is averaging $62,000 per quarter in contract maintenance. Any new systems sales going forward will increase this figure incrementally, typically adding $7,500k per quarter per sale.

o   For corrective maintenance, MedClean has averaged $74,000 per quarter over the past eight quarters. This number will fluctuate quarterly, but management expects the amount to remain close to its running average per quarter going forward.

o   MedClean’s new ecommerce line of business (MedClean GPO), which was launched in the third quarter, generated $24,000 for the third quarter. Management expects this to ramp to a quarterly run rate of approximately $60,000 starting in Q1 2012. Additional upside is attainable as the current annual market for disposal sharps alone is $280 million and the Company will also be selling other mainstream consumable products such as red bags, autoclave bags, boxes, etc., that comprise an even greater annual market spend.

o   Consumables for MedClean Systems (cart liners, deodorizer, supplies, etc.,) are at a run rate of $34,500K per quarter and incremental system sales add approximately $3,000 to $5,000 per quarter.

o   In aggregate, MedClean is now at a quarterly revenue run rate of $194,500K and starting in Q1 2012, management expects to average approximately $250,000 per quarter for annual revenue (including the expected increase in ecommerce products and revenue associated with new sales plus revenue generated from the sale of consumables to our processing center/distributor partners). This equates to recurring revenue totaling $1.0 million, which is $103,000 greater than our total revenue reported for all of 2010.

o   The profit margin for MedClean’s recurring revenue streams is generally around 50%.

o   The current expected cash burn run rate is approximately $1.6 million annually. The cash burn run rate has decreased by 34% percent, or $77,000, per month compared to 2009 when the new management team took over and is currently 12% lower than one year ago. Major contributing factors include a 75% reduction in corporate headquarter expense, a reduction in lease payments from $21,000 per month in 2009 to $5,500 currently; a 44% decrease in wages and salaries through the first nine months of 2011 to $1.67 million compared to $2.3 million for the same period one year ago; and a reduction in third-party consulting services of $24,000 per month.  (The Company recently completed its relocation from Bethel, CT to Bethlehem, PA).

o   With the expected revenue of $1.0 million in consumable and maintenance revenue for 2012 at 50% margin, management expects gross profit from this division to be $500,000.  At the current cash burn rate of $1.6 million annually that leaves $1.1 million in annual cash burn before MedClean System sales and installations.

o   Through the first nine months of 2011, MedClean has sold and installed three systems.  By continuing on the same pace in 2012 the Company could achieve positive cash flow by selling and installing (or installing potions of backlog) four systems at an average price of $750,000, using current system sales margin of 35%

o   MedClean currently has nine deals in advanced stages in its pipeline that have been quoted and proposed at or above our target pricing level.  Management is currently negotiating specific project details on several installations for items in its backlog.  Of the nine deals, seven have been generated by MedClean’s distribution partners.

“The run rate for our current business, not including the incremental maintenance and consumable revenue from any additional system sales or further increases from our newly launched MedClean GPO business line, demonstrates that we have made significant strides in creating a self-sustaining, cash generating business model,” stated David Laky, President & CEO of MedClean Technologies, Inc. “The transformation of our business has taken longer than we initially expected, due in large part to the state of the business we inherited, but our efforts have culminated in the creation of a sustainable business model.  The expansion of our service offerings into an integrated waste stream service provider adds more opportunity for recurring service revenues and will continue to reduce our dependency on one time sales. As we further prove out our operating results and show the leverage we have developed within our operational model, we believe the market will respond in a positive manner.”

In addition to the operational update the Company has indicated above based on tangible results, there are also several other opportunities Management has positioned the company to take advantage of:

·         Develop “localized” waste processing center facilities at stand-alone locations, utilizing contracts with multiple nearby medical waste producers

o   MedClean is currently working with several partners to move forward on this venture and expect to finance the facilities in a joint venture structure utilizing a debt structure that will be based at the plant level.

o   Management’s initial goal has been to establish the operational model and infrastructure required to enable the Company to expand into a service and recurring revenue model. Expansion into the “localized” waste processing center model will leverage the Company’s new operational model and current infrastructure and will not impact  or extend the time it will take to achieve cash flow positive status.

o   Management has identified two partners at two separate locations where permitting and long-term waste contracts with surrounding medical facilities have conditionally been approved and would be utilized pending financial approval.

o   The Company expects to generate approximately $500,000 per year in revenue per facility based upon preliminary contract discussions with the surrounding waste generators and partners.

o   There are five to six additional locations that have been identified as potential follow-on locations with the model being repeatable in virtually any metropolitan area across the U.S. (the model requires only several millions of pounds of waste to be profitable).

Mr. Laky added, “Based on the business overview we have provided here today, and the progress we expect to achieve in the next few months, we anticipate conducting a conference call in conjunction with our fourth quarter and year-end financial disclosure. This call, which is expected to include a question and answer session for shareholders, is expected to be sometime in late March, pending timing of our year-end audit. We feel this will provide the best forum to provide additional color on our progress as over the past six months we have been predominantly focused on operations of the company.”

Third Quarter Financial Results:

Total revenue for the quarter ended September 30, 2011 was $602,947 compared with $306,825 for the same period in 2010, an increase of  $296,121 million, or 96.5%.  In 2011 the Company was able to deliver systems completing contractual obligations and meeting revenue recognition policies totaling $445,200 versus $0 for the period in 2010.  Revenues derived from the sale of consumables, component parts, service billings, and amortization of maintenance contracts decreased by $149,079 or 48.6% in the current quarter to $157,146.  The decrease in service billings was a result of fewer service calls required due to equipment issues. Service billings will continue to fluctuate period to period based upon equipment service requirements.

Gross profit on system revenue during the three months ended September 30, 2011, was $156,443 compared to $0 for the same period in 2010. Gross profit on the sale of consumables, component parts, service billings and amortization of maintenance contracts during the three months ended September 30, 2011, was $91,608 compared to $253,741 for the same period in 2010.

Net loss for the three month period ended September 30, 2011, was $648,746, compared to a loss of $750,158 for the same period in 2010.

Year-To-Date Financial Results:

Total revenue for the nine months ended September 30, 2011, was $1,387,127, compared with $707,450 for the same period in 2010, an increase of $679,677 or 96.1%. System revenue during the nine month ended September 30, 2011, was $895,200, compared to $0 in 2010. The increase in system revenue was the result of the completion of the Company’s first containerized system and the installation of a fixed based system. Revenues derived from the sale of consumables, component parts, service billings and amortization of maintenance contracts decreased by $215,523 or 30.5% in the current period to $491,927. The decrease in service billings was a result of fewer service calls required due to equipment failure. Service billings will continue to fluctuate from period to period based upon equipment failure, whether through operator error or wear and tear, and pre-scheduled service activities such as equipment relocation. Service revenue attributable to contract revenues is recognized at the time of performance and not at the time of contract execution.

The Company has filed its Form 10-Q for the period ended September 30, 2011 with the Securities and Exchange Commission, and investors are encouraged to visit www.sec.gov to review this document, which includes financial tables and additional detail for the quarter ended September 30, 2011.

About MedClean Technologies, Inc.

MedClean Technologies, Inc. is a provider of innovative technology and services for the onsite treatment and disposal of regulated medical waste. MedClean's flagship MedClean® Series systems are fully integrated, turnkey technology solutions that enable hospitals and other healthcare providers to safely, efficiently, and cost-effectively convert bio-hazardous regulated medical waste into sterile, unrecognizable material suitable for disposal as municipal solid waste. MedClean was founded in 1997 with corporate headquarters, research and development and distribution facilities located in Bethlehem, Pennsylvania. Further information on MedClean can be found at www.medcleantechnologies.com and in filings with the Securities and Exchange Commission found at www.sec.gov.

Statements about our future expectations are "forward-looking statements" within the meaning of applicable Federal Securities Laws, and are not guarantees of future performance. When used herein, the words "may," "will," "should," "anticipate," "believe," "appear," "intend," "plan," "expect," "estimate," "approximate," "potential" and similar expressions are intended to identify such forward-looking statements. These statements involve risks and uncertainties inherent in our business; including those set forth in our most recent Annual Report on Form 10-K for the year ended December 31, 2010, filed with the SEC on March 31, 2011, and other filings with the SEC, and are subject to change at any time. Our actual results could differ materially from these forward-looking statements. We undertake no obligation to update publicly any forward-looking statement.

Contact:

Cameron Donahue

Hayden IR

(651) 653-1854

Enhances Triumvirate Environmental Services to Include Integrated Medical Waste Disposal Services to Complement Environmental Waste Services already Provided to Current Customer Base

BETHLEHEM, Penna., October 20 /PRNewswire-FirstCall/ — MedClean Technologies (OTC Bulletin Board: MCLN), the leading provider of onsite technology for the treatment and disposal of medical waste and the destruction of confidential documents and related media, today announced it has partnered with Triumvirate Environmental, a full-service environmental firm specializing in consulting, waste disposal, engineering and remediation. This agreement will enable Triumvirate Environmental to provide onsite integrated medical waste disposal and document destruction technology and services to build upon the existing program and compliment its hazardous waste management and disposal services. The structure of the agreement enables both companies to collaborate on and target their integrated technology and services to Triumvirate’s extensive customer base that already includes 25 of the 26 largest health organizations in the Northeast United States.

“Triumvirate Environmental has the option to offer medical waste disposal onsite, or create off-site processing centers and services to hospital clients with a MedClean System that complements their hazardous waste management and disposal business,” commented Dave Laky, President and CEO, MedClean Technologies, Inc.  ”This alliance provides further validation that MedClean’s treatment technology offers the flexibility to handle a hospital’s onsite processing needs or can be set up in a manner to support localized waste processing for a service bureau approach waste processing.  Our technology continues to offer superior cost savings, risk mitigation, and quality to the health care community and when integrated with services already provided by a leader in customer service, compliance, and efficiency the combination provides value unrivaled in the industry. Triumvirate is the fastest growing environmental services firm in the country and we are proud to team up with and share their vision to provide the best in service and value to our customers.”

“Triumvirate is excited about its partnership with MedClean Technologies as we add another dimension of service and disposal to our comprehensive waste management strategy,” added John McQuillan, President and CEO of Triumvirate Environmental. “MedClean’s technology is a natural extension to our environmentally focused business strategy.  Our relationship with MedClean Technologies will enable us to incorporate their technology as part of our overall service offering to a customer or in instances where the customer chooses to purchase the equipment, we will be able to expand our quality services through on site collection of the medical waste as well as operation of the equipment. The combination of equipment, services, and expense reduction results in a powerful solution for our customer base.”

About Triumvirate Environmental

Triumvirate is America’s fastest growing environmental services firm, providing long-term, sustainable solutions through its consulting, waste disposal, engineering, and remediation practices.

Recognized as a leader in customer service, the Triumvirate team demonstrates an incomparable level of commitment to their clients, ensuring compliance, efficiency, and the safest possible work environment. Triumvirate prides itself in providing effective and manageable hazardous and medical waste programs of all scopes to higher education, healthcare, industrial, and life sciences organizations. Dedicated to building an environment where health and safety professionals can seek expert insight, analysis, and solutions to meet their sustainability and efficiency goals, Triumvirate values trust as much as it does service and reliability. To learn more about the firm, please visit www.triumvirate.com.

About MedClean Technologies, Inc.

MedClean Technologies, Inc. is a provider of innovative technology and services for the onsite treatment and disposal of regulated medical waste. MedClean’s flagship MedClean® Series systems are fully integrated, turnkey technology solutions that enable hospitals and other healthcare providers to safely, efficiently, and cost-effectively convert bio-hazardous regulated medical waste into sterile, unrecognizable material suitable for disposal as municipal solid waste. MedClean was founded in 1997 with corporate headquarters, research and development and distribution facilities located in Bethel, Connecticut. Further, information on MedClean can be found at www.medcleantechnologies.com and in filings with the Securities and Exchange Commission found at www.sec.gov.

Statements about our future expectations are “forward-looking statements” within the meaning of applicable Federal Securities Laws, and are not guarantees of future performance. When used herein, the words “may,” “will,” “should,” “anticipate,” “believe,” “appear,” “intend,” “plan,” “expect,” “estimate,” “approximate,” “potential” and similar expressions are intended to identify such forward-looking statements. These statements involve risks and uncertainties inherent in our business, including those set forth in our most recent Annual Report on Form 10-K for the year ended December 31, 2010, filed with the SEC on March 31, 2011, and other filings with the SEC, and are subject to change at any time. Our actual results could differ materially from these forward-looking statements. We undertake no obligation to update publicly any forward-looking statement.

Important information regarding MedClean Technologies and our go forward strategy.

Kind Regards,

MedClean

Perfect Fit! ~ The 1st Picture of Barnett Medical Services MedClean System Treatment Facility

The MedClean System Container offers so many unique benefits from the obvious portability to the self-containment and small footprint.  It is truly a unique opportunity for independent medical waste transporters to take advantage of if considering building their own medical waste treatment facility or expanding from their current space.  It also offers unique benefit to hospitals, disaster relief situations, and to those considering joint venture processing facilities with the use of The MedClean Container System. 

Stay tuned for more container photos.

Kind Regards,

MedClean   

With this relationship, Covidien’s national sales force for SharpSafety products will promote MedClean products and services in a complimentary manner to MedClean’s existing Distributor sales force. As a result of this relationship with Covidien, and the MedAssets relationships already in place, MedClean will have multiple sales professionals promoting the Company in nearly every hospital in the U.S. In addition, MedClean will sell and distribute Covidien’s market-leading sharps and waste containers.

“This relationship is our largest co-promotion arrangement to date, broadening the exposure of our products and connecting MedClean with nearly every hospital in the country,” commented David Laky, MedClean’s President and CEO.  “One of the goals of this co- promotion relationship is to ensure the market is educated about disposable sharps versus reusable sharps and the benefits, through safety and expense reduction, that disposable sharps programs provide to healthcare facilities. We estimate the market for sharps containers to exceed $280million annually, and capturing a significant share of this market is a priority for both companies. We are excited to collaborate with Covidien and look forward to a long and mutually productive relationship.”

MedClean now has approximately 98 sales professionals in 50 states plus Canada promoting the Company’s innovative Technology enabled Solutions (TeS) for the treatment and disposal of medical waste and the destruction of confidential documents and related media.

“The extended sales cycle and the process for educating sales professionals on the benefits and details of our systems takes about six to nine months,” added Mr. Laky. “We continue to see distributors ramping up their lead generation efforts over this time frame, and as such we believe we will see an acceleration of our sales in the coming quarters due to the many relationships we have brought on board in the last year.”

About MedClean Technologies, Inc.

MedClean Technologies, Inc. is a provider of innovative technology and services for the onsite treatment and disposal of regulated medical waste. MedClean's flagship MedClean® Series systems are fully integrated, turnkey technology solutions that enable hospitals and other healthcare providers to safely, efficiently, and cost-effectively convert bio-hazardous regulated medical waste into sterile, unrecognizable material suitable for disposal as municipal solid waste. MedClean was founded in 1997 with corporate headquarters, research and development and distribution facilities located in Bethel, Connecticut. Further information on MedClean can be found at www.medcleantechnologies.com and in filings with the Securities and Exchange Commission found at www.sec.gov.

Statements about our future expectations are "forward-looking statements" within the meaning of applicable Federal Securities Laws, and are not guarantees of future performance. When used herein, the words "may," "will," "should," "anticipate," "believe," "appear," "intend," "plan," "expect," "estimate," "approximate," "potential" and similar expressions are intended to identify such forward-looking statements. These statements involve risks and uncertainties inherent in our business; including those set forth in our most recent Annual Report on Form 10-K for the year ended December 31, 2009, filed with the SEC on March 3, 2010, and other filings with the SEC, and are subject to change at any time. Our actual results could differ materially from these forward-looking statements. We undertake no obligation to update publicly any forward-looking statement.

We look forward to posting more information regarding the IMWTA Event being held next Tuesday in Dallas, TX at the Waste Expo.

Kind Regards,

MedClean

BETHEL, Conn., April 28, 2011 /PRNewswire-FirstCall/ — MedClean Technologies, Inc. (OTC Bulletin Board: MCLN) today announced financial results for the first quarter ended March 31, 2011.

Operating highlights include:
• Completion of the Company’s first containerized system. This system will be implemented in a west coast waste-processing center. The processing center is expected to be operational in the second quarter 2011.
• Gross Margins increased from 38.5% to 48.5% compared to the same period last year. The increase in gross margin is a result of the Company converting backlog into revenue in an efficient manner.
• MedClean’s backlog was $1.7 million as of March 31, 2011, compared to $986,657 as of March 31, 2010.

“We are excited that our first container is being deployed and that it also coincides with the establishment of a localized waste processing center,” stated David Laky, President & CEO. “This milestone also marks the start of the Company converting our backlog to revenue. Our vision has begun to culminate into financial results as our business model has started to deliver tangible results, but we also recognize we are still in the early stages and true progress will be evident only when we reach scale in our business. We still must build quarter by quarter as we move forward, but the groundwork we have laid has set the stage for the Company to have better visibility into our future.”

Mr. Laky concluded, “The Company has developed programs to diversify risk associated with depending on large capital sales. Our rental program is showing great promise, the establishment of localized processing centers will contribute to both direct sales revenue and recurring per-pound revenue in certain circumstances, and our e-commerce platform has begun to take shape and may contribute in a manner that exceeds what we had first envisioned. Our partners have done an excellent job developing leads, pipeline, and supporting programs in conjunction with our vision and we expect positive results from those relationships over the next three quarters.”

First Quarter Financial Results

Total revenue for the quarter ended March 31, 2011 was $593,624 compared with $268,867 for the same period in 2010, an increase of $324,757 or 120.8%. System revenues during the quarter was $450,000, compared to no system revenue in the first quarter last year. Revenues derived from the sale of consumables, component parts, service billings and amortization of maintenance contracts decreased by $125,243 or 46.6% in the current quarter to $143,624. The decrease in service billings was a result of fewer service calls. Service billings will continue to fluctuate period to period based upon equipment failure, whether through operator error or wear and tear, and pre-scheduled service activities such as equipment relocation. Service revenue attributable to contract revenues is recognized at the time of performance and not at the time of contract execution.

The gross profit for the first quarter of 2011 was $287,709 (48.5% of total revenue) compared with a gross profit of $103,414 (38.5% of total revenue) for the same three-month period of 2010.

Total operating expenses for the first quarter of 2011, was $941,687 compared with $1.7 million for the same three month period in 2010, a decrease of $744,140. In the three months ended March 31, 2011, MedClean recognized non-cash equity based compensation to service providers and employees of $352,733 as compared to $1.1 million recorded as equity based compensation for the three months ended March 31, 2010.

MedClean reported a loss from operations for the first quarter of 2011 of $653,978, compared to a loss from operations of $1,582,413 for the first quarter last year. Net loss for the quarter was $1,126,496, or $0.00 per share, compared to a net loss of $1,585,104, or $0.00 per share last year.

Additional financial detail, including full financial statements, are available in the Company’s quarterly report on Form 10-Q filed with the Securities and Exchange Commission and available at www.sec.gov.

About MedClean Technologies, Inc.
MedClean Technologies, Inc. is a provider of innovative technology and services for the treatment and disposal of regulated medical waste. MedClean’s flagship MedClean® Series systems are fully integrated, turnkey technology solutions that enable hospitals and other healthcare providers to safely, efficiently, and cost-effectively convert bio-hazardous regulated medical waste into sterile, unrecognizable material suitable for disposal as municipal solid waste. MedClean was founded in 1997 with corporate headquarters, research and development and distribution facilities located in Bethel, Connecticut. Further information on MedClean can be found at www.medcleantechnologies.com and in filings with the Securities and Exchange Commission found at www.sec.gov.

Statements about our future expectations are “forward-looking statements” within the meaning of applicable Federal Securities Laws, and are not guarantees of future performance. When used herein, the words “may,” “will,” “should,” “anticipate,” “believe,” “appear,” “intend,” “plan,” “expect,” “estimate,” “approximate,” “potential” and similar expressions are intended to identify such forward-looking statements. These statements involve risks and uncertainties inherent in our business; including those set forth in our most recent Annual Report on Form 10-K for the year ended December 31, 2009, filed with the SEC on March 3, 2010, and other filings with the SEC, and are subject to change at any time. Our actual results could differ materially from these forward-looking statements. We undertake no obligation to update publicly any forward-looking statement.

Contact:
Cameron Donahue
Hayden IR
(651) 653-1854

Year over Year Executed Purchase Agreements Increase 16.4%.  Backlog Increases 98.8% versus Q4 2009 and 11.4% Sequentially vs. Q3 2010

Formation of North American Distributor and Hauler Network and New Service Agreement Program Developed to Capitalize on Growing Market Opportunities in 2011

BETHEL, Conn., March 31, 2011 /PRNewswire-FirstCall/ — MedClean Technologies, Inc. (OTC Bulletin Board: MCLN) today announced financial results for the year ended December 31, 2010.

Operating highlights include:

• During the year, the Company entered into new purchase agreements for MedClean systems, the aggregate sales price totaling $1.4 million in 2010 versus purchase agreements totaling $1.2 million in 2009, an increase of $199,267 or 16.4%.  Due to revenue recognition policies, revenue and the timing of the orders, revenue from these orders is expected to be recognized in 2011. The Company implemented a new policy in 2009 whereby revenue is only recognized upon the completion of the system installation versus the previous policy based upon percentage of completion.
• MedClean’s contracted backlog was $2.1 million as of December 31, 2010, up 11.4% sequentially from $1.9 million as of September 30, 2010 and up 98.8% from $1.1 million at December 31, 2009. The Company expects to recognize a significant portion of backlog during the first half of 2011.
• Three distributor partners (Barnett Medical, Gamma HealthCare, and Sunbelt Medical Systems) have purchased initial systems to establish waste processing centers in their respective territories. These systems are currently in backlog and are scheduled for delivery within the first three quarters of 2011. By developing regionalized processing centers in California, Tennessee and Arkansas, MedClean and its partners can now offer customers low cost, localized service, providing regionalized alternatives competing directly with Stericycle.

Business infrastructure highlights include:

• The Company has built a robust Certified Distributor Partner network with 10 solid organizations and 40-plus sales representatives dedicated to driving sales opportunities to MedClean.  To view important information regarding the MedClean distributor network please click here.
• MedClean has developed new waste hauling partnerships through its active involvement and sponsorship of the Independent Medical Waste Transporters Association (IMWTA.com). The IMWTA has 60 active members and continues to add new members weekly.
• MedClean has signed 10-plus qualified regional haulers to Mutually Beneficial Referral Agreements.  Under terms of the agreement MedClean will receive a portion of year-one revenue for referring business to the waste haulers. These same regional haulers will be trained and certified to operate MedClean’s equipment and will comprise the Company’s Certified Service Partner network.
• The Company, through its distributor and partner network has developed a pipeline of new business opportunities representing $30 million of potential business as of March 31, 2011. The continued growth of the sales pipeline indicates that demand in this market is strong and that MedClean appears to be well positioned to make an impact in the medical waste treatment and disposal market.
• The Company has introduced its new eCommerce platform. The platform enables existing customer to electronically purchase consumable supplies via the internet and has been extended to provide the benefits of group purchasing power to MedClean’s partner network, extending discounts on fleet services (tires, service, roadside assistance), office supplies, and other products and services directly related to day-to-day operations. The eCommerce business line is expected to grow modestly during 2011.

New Sales Support Programs:

·     MedClean has introduced a new service-based program the company has labeled Technology enabled Services (TeS). TeS represents a combination of MedClean equipment and related services provided by its distributor and waste hauling partners that provides the optimal combination of equipment and services in order to maximize savings, deliver quality services, and exceed efficacy standards.

• MedClean has forged exclusive relationships with industry consultants focused on best practices, actively working with more than 700 health care organizations to implement expense reduction programs for their medical waste streams. The program provides introduction of the MedClean TeS solutions to the highest levels of company management and should help shorten sales cycles and maximize customer ROI.
• MedClean has deployed a new Service Agreement financing program through the Company’s commercial finance entity MedClean Technologies Financial Services. The program is designed to eliminate the customer’s up-front costs while maximizing their ROI. The Service Agreement (while including equipment and services at a fixed price for a fixed period) operates similarly to a rental program, eliminating the need to qualify for long-term leasing or capital purchases, and can be renewed at the end of the term at a discounted rate or at the then current rates for the newest TeS offering.
• MedClean is now positioned to address the needs of both large and small quantity medical waste generators. Collaborating with a nationwide network of transporters enables the Company to leverage its technology to address customer needs while establishing a growing recurring revenue base. Furthermore, this collaboration serves as a catalyst for the company’s growing pipeline of business opportunities and provides access to all size waste generators, effectively doubling the Company’s target market. In the past the targeted market was limited to hospitals with 300 beds or higher.

“We continue to broaden our distributor sales network, introduce exciting new financing and partner programs, and develop our backlog,” commented David Laky, MedClean’s President and CEO. “While the length of the sales cycle continues to challenge us, we believe our distributors are moving forward on a variety of fronts and expect increased traction and sales growth during 2011. During the remainder of 2011 we expect to develop additional regionalized processing centers resulting in recurring service revenue. In addition, we plan to continue our traditional one-time equipment sales. Our network of Certified Service Partners and Certified Distributor Partners will be expanded as required, but we will focus primarily on converting pipeline opportunities into new business and completing product installations in order to convert backlog to revenue.  Based upon projects already underway in 2011 we anticipate first quarter revenue to be approximately $550,000.”

Mr. Laky concluded, “We have reached the point where the groundwork has been laid, the plans for rollout have been developed, obstacles in the sales cycle have been reduced or eliminated, and the distributor and hauler network has been built. The time is now for our collective organization, including our distributors and hauling partners, to produce tangible results. We expect 2011 to be a productive and exciting year.”

Full-Year Financial Results:

The Company reported revenue of $0.9 million, a decrease of 65% compared to $2.5 million for the year ended December 31, 2009. In 2009 the Company was able to deliver systems completing contractual obligations and meeting revenue recognition policies totaling $1.2 million. The Company did not have comparable revenue during 2010. Gross profit for 2010 was $0.5 million, or 52.4%, compared to gross profit of $1.3 million or 50.3% in the prior-year period. Net loss for the full-year was $(4.6) million, or $(0.01) per share, compared to a net loss of $(5.4) million, or $(0.01) per share for the same period in 2009.

Total Operating expense for 2010 was $4.8 million compared with $6.6 million for 2009, a decrease of $1.8 million.

The Company has filed its Form 10-K for the period ended December 31, 2010 with the Securities and Exchange Commission, and investors are encouraged to visit www.sec.gov to review this document, which includes financial tables and additional details for the year ended December 31, 2010.

Board of Directors

The Company also announced the appointment of Jay Bendis, an independent director, as Chairman of the Board of Directors, replacing Scott Grisanti, who announced his resignation as Chairman effective today. Mr. Grisanti will continue to serve as a director of the Company.

Mr. Bendis has been President of Transfer Technology Consultants during the past 15 years, a company that specializes in transferring new biotech product concepts from design to commercialization. From 2005 to 2008, he was President and CEO of Clinical Analysis Corp. He was Managing Partner in the Crystal Corridor Group that worked with Kent State University’s Liquid Crystal Institute in facilitating liquid crystal technology from 2000 to 2005. From 1995 to 2000 he served as Executive Vice President of American BioMedica Corp.  He was also President and Co-founder of Emerging Technology Systems, a Research and Development Company in the diabetic markets from 1993 to 1999. His prior management positions had been with XANAR Laser Corp, a division of Johnson & Johnson as the National Sales Manager and IVAC Corp, a division of Eli Lilly as Sales and Marketing Manager. He has also served as a member of the Edison BioTechnology Center Advisory Council for the State of Ohio and serves on the Boards of several private companies.

“I believe MedClean is poised for long-term sustainable growth and I am excited to help the management team accelerate sales efforts,” commented Mr. Bendis. “The sales cycle has been lengthy, but in 2010 the Company managed to build a robust North American sales network in conjunction with targeted programs for hospitals and waste generation facilities which highlight the ROI of MedClean’s offerings while eliminating many of the traditional sales barriers associated with selling into this market.”

About MedClean Technologies, Inc.

MedClean Technologies, Inc. is a provider of innovative technology and services for the  treatment and disposal of regulated medical waste. MedClean's flagship MedClean® Series systems are fully integrated, turnkey technology solutions that enable hospitals and other healthcare providers to safely, efficiently, and cost-effectively convert bio-hazardous regulated medical waste into sterile, unrecognizable material suitable for disposal as municipal solid waste. MedClean was founded in 1997 with corporate headquarters, research and development and distribution facilities located in Bethel, Connecticut. Further information on MedClean can be found at www.medcleantechnologies.com and in filings with the Securities and Exchange Commission found at www.sec.gov.

Statements about our future expectations are "forward-looking statements" within the meaning of applicable Federal Securities Laws, and are not guarantees of future performance. When used herein, the words "may," "will," "should," "anticipate," "believe," "appear," "intend," "plan," "expect," "estimate," "approximate," "potential" and similar expressions are intended to identify such forward-looking statements. These statements involve risks and uncertainties inherent in our business; including those set forth in our most recent Annual Report on Form 10-K for the year ended December 31, 2009, filed with the SEC on March 3, 2010, and other filings with the SEC, and are subject to change at any time. Our actual results could differ materially from these forward-looking statements. We undertake no obligation to update publicly any forward-looking statement.